×







We sell 100% Genuine & New Books only!

Beta 2-Agonists In Asthma Treatment 1997 Edition at Meripustak

Beta 2-Agonists In Asthma Treatment 1997 Edition by Romain Pauwels,Paul O'Byrne, Taylor & Francis

Books from same Author: Romain Pauwels,Paul O'Byrne

Books from same Publisher: Taylor & Francis

Related Category: Author List / Publisher List


  • Price: ₹ 12662.00/- [ 21.00% off ]

    Seller Price: ₹ 10003.00

Estimated Delivery Time : 4-5 Business Days

Sold By: Meripustak      Click for Bulk Order

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

We deliver across all postal codes in India

Orders Outside India


Add To Cart


Outside India Order Estimated Delivery Time
7-10 Business Days


  • We Deliver Across 100+ Countries

  • MeriPustak’s Books are 100% New & Original
  • General Information  
    Author(s)Romain Pauwels,Paul O'Byrne
    PublisherTaylor & Francis
    ISBN9780824794965
    Pages472
    BindingHardback
    LanguageEnglish
    Publish YearJuly 1997

    Description

    Taylor & Francis Beta 2-Agonists In Asthma Treatment 1997 Edition by Romain Pauwels,Paul O'Byrne

    This authoritative, timely resource analyzes every important topic related to the most frequently prescribed anti-asthma medications-comprehensively examining the use of beta2-agonists from molecular interactions with the beta-receptor to clinical and therapeutic applications in acute and chronic conditions. Includes lively discussion sections that address controversies involving the use of beta2-agonists and synthesizes current information into practical treatment guidelines! Written by world-renowned experts representing prestigious institutions in 12 countries, Beta2-Agonists in Asthma Treatmentsummarizes the history of beta-agonists in asthma treatment explains the molecular action and effect of beta2-agonists on airway effector cells and inflammation discusses in detail beta2-agonist pharmacokinetics reviews inhalation devices and techniques compares the pharmacological characteristics of long-acting versus short-acting beta2-agonists addresses the possible influence of beta2-agonists in the deterioration of asthmatic conditions and increased mortality delineates the role of beta2-agonists in treating acute and chronic asthma in both children and adults and much more!



    Book Successfully Added To Your Cart